Table 3.

Clinician Barriers to HPV vaccination (N=280)

How strongly would you agree or disagree that the following are barriers related to immunizing your patients against HPV?	Disagree, %	Neither Disagree/Agree, %	Agree, %	Missing, %
Your concerns about vaccine safety	45.4	10.7	43.2	0.7
Your concerns about vaccine efficacy	63.2	18.9	17.9	0
Discussing sexuality/sexually transmitted infections	42.1	14.6	41.8	1.4
Vaccinated teens practicing riskier sexual behaviors	61.8	18.2	20.0	0
Administering a new vaccine with a limited track record of safety	42.9	15.4	41.8	0
Adding another vaccine to the vaccine schedule	41.8	14.6	43.6	0
Lack of information about the HPV vaccine	58.6	16.4	24.6	0.4
The upfront cost of purchasing private stock HPV vaccine	62.1	26.8	10.4	0.7
The cost of stocking HPV vaccine	67.9	25.4	6.4	0.4
Lack of adequate reimbursement for HPV vaccination	65.0	27.1	7.1	0.7
Failure of some insurance companies to cover the cost of vaccination	51.8	24.3	23.6	0.4
The time it takes to discuss HPV vaccination with patients and/or parents	54.3	16.4	28.9	0.4
Difficulty ensuring that patients will complete the 3-dose HPV vaccination series	38.2	20.0	41.4	0.4
HPV vaccination is not required for school attendance	29.3	20.0	50.4	0.4

Abbreviations: HPV, Human Papillomavirus